National Research Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.1
- Today's High:
- $3.1
- Open Price:
- $3.1
- 52W Low:
- $34.3898
- 52W High:
- $47.3412
- Prev. Close:
- $45.35
- Volume:
- 0
Company Statistics
- Market Cap.:
- $1.03 billion
- Book Value:
- 3.166
- Revenue TTM:
- $148.47 million
- Operating Margin TTM:
- 28.11%
- Gross Profit TTM:
- $94.52 million
- Profit Margin:
- 19.65%
- Return on Assets TTM:
- 19.33%
- Return on Equity TTM:
- 39.86%
Company Profile
National Research Corp had its IPO on 1997-10-10 under the ticker symbol NRC.
The company operates in the Healthcare sector and Health Information Services industry. National Research Corp has a staff strength of 491 employees.
Stock update
Shares of National Research Corp opened at $3.1 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of $3.1 - $3.1, and closed at $3.1.
This is a +0.57% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of National Research Corp have increased by +8.49%.
National Research Corp's Key Ratios
National Research Corp has a market cap of $1.03 billion, indicating a price to book ratio of 13.587 and a price to sales ratio of 6.0751.
In the last 12-months National Research Corp’s revenue was $148.47 million with a gross profit of $94.52 million and an EBITDA of $47.32 million. The EBITDA ratio measures National Research Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, National Research Corp’s operating margin was 28.11% while its return on assets stood at 19.33% with a return of equity of 39.86%.
In Q2, National Research Corp’s quarterly earnings growth was a negative -12.1% while revenue growth was a negative 3%.
National Research Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 35.6271
- PEG
Its diluted EPS in the last 12-months stands at $1.18 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into National Research Corp’s profitability.
National Research Corp stock is trading at a EV to sales ratio of 6.0348 and a EV to EBITDA ratio of 17.4682. Its price to sales ratio in the trailing 12-months stood at 6.0751.
National Research Corp stock pays annual dividends of $0.6 per share, indicating a yield of 1.14% and a payout ratio of 41.03%.
Balance sheet and cash flow metrics
- Total Assets
- $133.63 million
- Total Liabilities
- $33.74 million
- Operating Cash Flow
- $-4339000.00
- Capital Expenditure
- $4.34 million
- Dividend Payout Ratio
- 41.03%
National Research Corp ended 2024 with $133.63 million in total assets and $0 in total liabilities. Its intangible assets were valued at $133.63 million while shareholder equity stood at $77.75 million.
National Research Corp ended 2024 with $0 in deferred long-term liabilities, $33.74 million in other current liabilities, 31000.00 in common stock, $-16849000.00 in retained earnings and $61.61 million in goodwill. Its cash balance stood at $22.50 million and cash and short-term investments were $22.50 million. The company’s total short-term debt was $4,606,000 while long-term debt stood at $15.36 million.
National Research Corp’s total current assets stands at $40.99 million while long-term investments were $0 and short-term investments were $8.69 million. Its net receivables were $12.10 million compared to accounts payable of $2.15 million and inventory worth $5.55 million.
In 2024, National Research Corp's operating cash flow was $-4339000.00 while its capital expenditure stood at $4.34 million.
Comparatively, National Research Corp paid $0.41 in dividends in 2024.
Other key metrics
- Current Trading Price
- $3.1
- 52-Week High
- $47.3412
- 52-Week Low
- $34.3898
- Analyst Target Price
- $
National Research Corp stock is currently trading at $3.1 per share. It touched a 52-week high of $47.3412 and a 52-week low of $47.3412. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $43.11 and 200-day moving average was $42.89 The short ratio stood at 5.61 indicating a short percent outstanding of 0%.
Around 4180.8% of the company’s stock are held by insiders while 4747.2% are held by institutions.
Frequently Asked Questions About National Research Corp
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.